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Abstract 
Intraperitoneal injection of phenyl~p-benzoquinone 
(PBQ) was used in three experiments to evaluate ~ts action 
as a potential model for the study of "pain" processes. 
Pain is operationally defined as: behavior which would be 
interpreted as pain related in man, specific actions of 
ana1gesic drugs to reduce this behavior, and ability of 
other pain producing chemicals to substitute for the PBQ 
treatment. In the first experiment PBQ administration 
produced dose-dependent writhing in hooded rats. This 
behavior was blocked by the narcotic analgesic, morphine, 
also in a dose dependent manner. In the second experiment 
20 subjects were trained to respond on a fixed ratio 10 
schedule for 
available for 
reinforcement 
food reinforcement. 
responding. One 
only following an 
Two manipulanda were 
of the levers produced 
injection of PBQ, and 
responses on the other were only reinf arced following a 
saline 
trials 
injection. 
indicated 
Observation of performance over many 
that PBQ was acting as a discriminative 
stimulus by significantly influencing lever choice prior 
to the delivery of reinforcement. However, the task was 
acquired with difficulty, was maintained at a low level of 
accuracy, and PBQ treatment was extremely toxic when given 
chronically. Procedural changes were incorporated in the 
third experiment to reduce or eliminate these problems. 
The dose of PBQ was levered from 1.25 mg/kg to 0.62 mg/kg, 
and the saline injection was omitted on non-PBQ trials. 
It was replaced by a handling treatment without injection. 
Twenty-six of a total of 49 subjects acquired the task, 
and a level of accuracy vas maintained which permitted the 
application of experimental treatments. The subjects all 
met a criterion level of performance of 9 or fewer 
responses on the incorrect lever prior to the first 10 
responses on the correct lever for 8 out of 10 consecutive 
trial days. 
Discrimination of the PBQ injection was dose related, 
with an ED 50 of 0.21 mg/kg representing the average 
threshold. Neither decreased toxicity nor increased ease 
of acquisition resulted from the procedural changes. An 
injection of saline administered in place of PBQ elicited 
PBQ -appropriate lever selection in 40% of the subjects; 
indicating that the discriminative stimulus vas a 
compound, with PBQ irritation the primary component and 
probable irritation from the injection procedure a 
secondary component. Injection of histamine produced PBQ 
lever selection in a significant majority of the subjects 
tested. These data suggest that the discriminative 
property of PBQ treatment is its irritant quality since 
this action is common to both PBQ and histamine. 
To further study the validity of PBQ discrimination 
as a model of subjectively experienced aversive stimuli 
for investigation of pain related behavior, two analgesics 
and several other centrally acting drugs were administered 
with PBQ treatment on certain test trials. Both the 
narcotic analgesic morphine, and non-narcotic analgesic 
aspirin produced significant blockade of PBQ 
discrimination at doses which did not significantly affect 
response rate, 
linear function 
and the blocking action was a significant 
of ascending dose for morphine but not 
Librium and haloperidol did not significantly aspirin. 
affect PBQ 
depressed 
discrimination at doses 
responding. Pentobarbital 
which 
and 
severely 
amitriptyline 
interfered significantly with PBQ discrimination at one of 
several doses tested, but in a manner which excluded the 
effect as evidence of analgesic action. There was no 
significant dose-related blockade of discrimination by 
either drug, and the level of interference did not 
approach the effect of the .two analgesic compounds tested. 
It was concluded that PBQ treatment discrimination is 
based on both ~enscry and aversive components which are 
necessary to validate the task as a model of subjective 
pain processes. However, the problems of toxicity and 
performance reliability must be overcome before it can be 
used as a practical screening procedure for evaluating 
analgesic drug effects. 
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General Introduction 
Pain is an experience which includes both sensory and 
emotional components. When it functioris as a 
discriminative stimulus, allowing us to avoid or escape 
present or impending physical harm, it is a healthy 
perceptual process. Pain which accompanies chronic 
illness or outlasts injury or disease is not useful, and 
can disrupt purposeful behavior. 
Treatment for pathological pain is given primarily in 
the form of analgesic medication. Several experimental 
animal models presently exist for evaluating the potential 
analgesic activity of pharmacological and other treatment 
approaches • . Many of these models are based on 
reactive-reflexive behavior which does not accurately 
measure pain as a subjective aversive experience. Operant 
procedures for assessing analgesic treatments are more 
sensitive to drug effects on subjective experience, but 
have concentrated on cutaneous stimulation and are subject 
to criticism on a number of methodological grounds. The 
following research is an investigation of a new model for 
the objective study of analgesic effects on subjectively 
experienced, chemically induced, interoceptive pain. 
1 
Background 
aeactive-reflexive Methods for Measuring Analgesia 
Thermal 
The first use of heat to produce experimental pain 
was reported by Goldscheider in 1894. Since that time, 
the greatest impetus and inspiration for further 
investigation of thermal stimulation came from a study by 
Hardy, Wolfe and Goodell in 1940. First done in humans, 
the procedure involved application of radiant heat from a 
lamp or other source at a fixed duration. Intensity vas 
increased until pain was reported. According to this 
test, a temperature of 45.5°centigrade was the reaction 
threshold in man, rat and guinea pig. The modification of 
this procedure by D1 A~our and Smith (1941) is still one of 
the most widely used methods of producing experimental 
pain for assay of drug effects in animals. Light rays are 
focused on the tip of a rat•s tail with steadily 
increasing intensity until it is withdrawn. Failure to 
move the tail after an exposure of a certain duration is 
indicative of analgesia. 
Several methods for 
contact were introduced 
application of heat by direct 
by Andrews and Workman (1941), 
Wolfe and Macdonald (1944), Ben-Bassat et al. ( 1959), and 
Janssen et al. (1963). The production of a "skin-twitch" 
2 
in the dog through exposure to a radiant heat stimulus was 
studied by Andrews and Workman. This method has since 
been examined using rats (Tainter and Buchanan, 1949) and 
guinea pigs (Winder, 1947). 
Paw 
placed on 
iolfe and 
licking followed by an escape response in mice 
a heated surface (hot plate) was observed by 
Macdonald, who subsequently introduced this 
procedure for assaying the analgesic activity of drugs. 
ihen the tail of a rodent, either mouse (Ben-Bassat 
et al. 1959), or rat (Janssen et al. 1963), is placed in a 
container holding a heated liquid; the latency of the 
tail-withdrawal response can also be used as a measure of 
pain sensitivity which can be modified by the 
administration of drugs. 
With the exception of the "skin-twitch" procedure, 
these methods appear to be equally sensitive to the 
analgesic action of morphine, yielding an EDSO of 
approximately 3 mg/kg. The ED50 for reduction of 
"skin-twitch" is significantly greater. 
Electrical 
Application of electrical current to the skin surface 
on different areas of the body is frequently used as a 
model of pain. 
greater frequency. 
It is also criticized with equal or 
Application of shock is quite simple, 
3 
but control is particularly difficult. 
Shock stimulation applied to the scotal sacs of rats 
was used by Thorpe (1946), and on the skin by Monje• and 
Ritter (1959). The presence or absence of a behavioral 
reaction at a certain voltage and amperage was the measure 
of sensitivity. Although the variability of the results 
was extreme in both studies, the authors felt that it is a 
useful method for assay of analgesic properties of new 
drugs. 
Electrical stimulation of exposed tooth pulp has been 
used in cats (Scott and Tempel, 1963), guinea pigs 
(Wilder-Smith et al. 1963) and rabbits (Leaders and 
Keasling, 1962). 
Shock has also been applied .to the surface of tails 
of rats (Charpentier, 1962) and mice (Grewal, 1952) with 
an escape or vocalization response as the measure of 
nociceptive sensitivity. This procedure has been found 
effective by some investigators. Maxwell et al. (1961) 
were able to shov parallel dose-response functions for 
morphine and codeine, with an ED50 of approximately 2 
mg/kg for morphine. Other studies have found the method 
both insensitive and highly variable. Although response 
threshold was raised by 78% in the Charpentier study 
(1962), this was not a significant difference from 
baseline. McKenzie and Beechy (1962) could find only a 
barely detectable analgesic effect of 10 mg/kg morphine. 
4 
Even insertion of the electrodes beneath the skin of the 
tail failed to reduce threshold variability (Nilsen, 
1961) • 
Reactivity to 
through a grid on 
"flinch-jump" test, 
assessing a drug's 
shock is delivered 
electrical stimulation introduced 
which the animal stands, called the 
is another method proposed for 
analgesic effect (Evans. 1961). Pav 
in both ascending and descending 
series. After each 0.1 second shock an animal is scored 1 
(no response), 2 (flinch, or any reflexive movement of the 
body except that both rear paws do not leave the grid), or 
3 (jump response, a reflexive movement in which both rear 
paws leave the grid). Each intensity of shock is usually 
delivered several times, and both flinch and jump 
threshold are calculated as the milliamperage at which an 
animal exhibited that response at least 5 out of 10 
trials; as in Harvey et al. 1975. Evans (1961) found 
aspirin (100-750 mg/kg) and morphine (2-5 mg/kg) effective 
analgesics in this test. but the data does not allow a 
direct computation of ED 50. 
Mechanical 
In animal 
deformation of 
observations of 
models the 
tissue has 
the effect 
production of 
been primarily 
of application 
"pain" by 
limited to 
of gross 
pressure. These mostly involve paws or tails of rodents, 
5 
as seen in the early experiments of Haffner (1929) and 
Eddy (1932), which were popular prior to the thermal 
techniques of Hardy, Wolfe and Good~ll (1940) mentioned 
earlier. 
Vocalization has been the main indicant response, 
although it is frequently combined with "struggle" (Eagle 
and Carlson, 1950; Green et al. 1951). In these studies a 
sharp or blunt tipped metal rod was used, and pressure was 
measured by means of a scale, in grams; or in centimeters 
of mercury. The method that has received the most 
attention in recent years involves the application of 
increasing levels of pressure to a rodent's hind paw, 
which has been rendered hypersensitive by a subcutaneous 
injection of brewers yeast (Randall and Selitto, 1957). 
Both narcotic and salicylate analgesics effectively 
increase pressure tolerance in this test. Eagle and 
Carlson (1950) criticize the Randall-Selitto technique as 
cumbersome and difficult to administer because of the 
necessity of controlling the animal's paw position, and 
its insensitivity without the presence of inflammation. 
Collier tl .a.J... ( 1961) prefer a more simplified 
procedure of applying artery clips to the toes of guinea 
pigs, and 
squeaks. 
stimulus 
morphine 
counting the number and frequency of resulting 
Here, precise quantification of the pressure 
is not possible, but the resulting EDSO for 
in reducing squeaks was comparable to the 
6 
Randall-Selitto method. 
Each of the methods has its own specific advantages 
over the others, but they are approximately equal in 
sensitivity. A dose of three to five milligrams _per 
kilogram of morphine given intraperitoneally or 
subcutaneously, or 180 to 750 milligrams per kilogram of 
aspirin orally, yields detectable analgesia by each of the 
procedures. 
Chemical 
Injection of chemicals that produce general or 
localized irritation through inflammation or other action 
is a frequently used analgesic assay procedure. 
Phenyl-p-benzoquinone is a substance which causes 
centrally mediated abdominal muscle spasms in both rats 
and mice (Siegmund et al. 1957). These spasms are seen as 
a "writhing" response, or "extensions of the hind legs and 
twisting of the trunk". The writhing behavior is blocked 
by both morphine (ED50=1.15 mg/kg subcutaneously) and 
aspirin (ED50=160 mg/kg orally). Local anesthetics can 
block the writhing response (Vanderwende and 
Margolin, 1956), but not anticholinergics or 
antispasmodics (Siegmund et al. 1957). The release of 
serotonin or histamine does not seem to be involved 
(Eckhardt et al. 1958). 
7 
Bradykinin has also been used as a writhe inducing 
agent in similar experiments (Emele and Shanaman, 1963) as 
well as acetic acid (Niemegeers et al. 1975; Kokka and 
Fairhurst, 1977) and sodium-iodomethamate (Vander Wende 
and Margolin, 1956). 
Recently, ethacrinic acid; a sulfhydryl reagent, vas 
found to elicit a phenyl-quinone-like writhing syndrome 
that is antagonized by morphine (EDS0=0.42 mg/kg 
subcutaneously), aspirin (ED50=88 mg/kg orally), and 
imipramine (ED50=5.2 mg/kg orally) (Jaques, 1977). 
This method appears to be more sensitive to analgesic 
effects of the test drugs. The dose of morphine needed to 
produce an EDSO reduction in writhing is lower than with 
comparable doses of phenyl-quinone, and the writhing is 
also blocked by other psychotropic and non-steroidal 
anti-inflammatory drugs (Jaques, 1977). 
Summary of Reactive-reflexive Analgesic Assay Techniques 
Each of the foregoing nociception-inducing stimulus 
modes and techniques for their application and subsequent 
measurement of nociceptive responses, has individual 
advantages and disadvantages. They must be compared 
within a stimulus category because the separate modes of 
stimulation represent separate "pain" qualities. With 
regard to sensitivity to the effects of narcotic and 
non-narcotic analgesics, the stimuli may be compared. 
8 
Thermal, electrical, mechanical, and chemical modalities 
are all sensitive to analgesic effects of narcotics, but 
the chemical methods are the only procedures which are 
optimally sensitive to both narcotic and non-narcotic 
analgesics. This is probably due to inflammation as the 
source of nociceptive stimulation. 
A common failing of all of the procedures concerns 
the nature · of the response indicative of the presence, 
absence, or degree of "pain" affected by the drug 
treatment. All of the .responses are primarily reflexive 
in nature. Thus, they produce data about reactivity 
rather than "pain" sensitivity (Winter, 1965). It is 
likely that subjective "pain" is already at a high level 
when the defensive reflex occurs (Goetzl et al. 1943; 
Miller, 1948; Beecher, 1957). Benjamin (1958) suggests 
that all reflexive "pain" indicators are actually 
side-effects of pain, and that an ideal analgesic should 
eliminate pain without affecting reflex activity. 
Therefore, the use of such behavior as "pain II indicators 
is undesireable. Most of the procedures also focus on 
cutaneous application of the stimulus, the only exception 
being the chemical approaches. 
An attribute of pain evaluation that has been 
neglected by these procedures is subjective report. A 
more realistic evaluation of the effect of analgesic 
treatments on the perception of nociceptive stimulation 
9 
should provide a quantitative measure of the subjectively 
experienced aversive stimuli. Attempts to develop such an 
animal model for evaluation of analgesic treatments can be 
seen in studies utilizing procedures based on Skinnerian, 
operant tasks. 
Operant Methods for Evaluation of Analgesics 
In 1954, Hill et al. studied the effect of morphine 
on the conditioned emotional response (CER). An auditory 
stimulus paire~ with unavoidable shock in one situation, 
normally suppresses food reinforced bar pressing by a 
trained animal upon later exposure to the stimulus. This 
behavioral suppression was blocked by morphine given 
subcutaneously at four to eight milligrams per kilogram of 
body weight. Other investigators have found that 
morphine's anti-suppression effect is abolished in highly 
trained animals (Domino et al. 1963), and it is 
ineffective in doses which do not produce overall 
suppression of behavior (Launer, 1963). Launer (1963) and 
others (Tenen, 1967) have since identified anti-anxiety 
drugs of the benzodiazepine class as most effective in 
blocking the CER. Thus, drug effects on CER performance 
are not considered to be directly related to analgesic 
activity. 
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According to a different paradigm, subjects are 
exposed to electric shocks of increasing magnitude through 
a grid floor. The shock increments can be slowed or 
reversed by engaging in operant behavior such as lever 
pressing. The met hcd is called "shock titration". The 
dependent measure is the maximum, or ceiling shock level 
tolerated by the subjects before lever pressing begins 
(Weiss and Laties, 1961). Salicylates (as in aspirin) and 
morphine 
before 
aspirin 
both raised the level of shock tolerated by rats 
avoidance lever pressing began. The dose of 
was 125 to 250 mg/kg orally, and 2.5 mg/kg 
morphine subcutaneously. In a similar procedure 
Mc Connell (1962) could not distinguish between effects of 
morphine . and the benzodiazepine anxiolytic 
chlordiazepoxide. This is because substances which effect 
response rate through either peripheral or central action 
may not be distinguished from analgesic drugs. 
Benzodiazepine catalepsy may appear as an analgesic effect 
since 
level 
response 
of shock 
rate is retarded, leading to an increased 
being delivered. However, Malis (1962) 
reported differences between opiates and salicylates on 
the one hand, and pentobarbital and chlorpromazine on the 
other. 
These findings indicate that the method has not 
always yielded consistent results, and is prone to false 
positive "analgesia" indications for drugs of different 
11 
classes. Also, whether or not a drug acts as an analgesic 
in this procedure depends on the schedule of shock 
delivery. Morphine and salicylates increase tolerated 
shock levels more if the shock is delivered every two 
seconds than if it is delivered every ten seconds (Weiss 
and Laties, 1961; Dykstra and Mc ~illan, 1977). Dykstra 
and Mc Millan compared several analgesics, including 
morphine and pentazocine, with drugs not considered 
clinically as analgesics; such as amphetamine and 
diazepam. All of these drugs caused an increase in the 
median tolerated shcck level when administered in the 
titration procedure. The authors did find a qualitative 
difference between morphine and the other drugs in that 
the maximum tolerated shock intensity was increased by 
morphine (3. O mg/kg) , while amphetamine ( 1. 0 mg /kg) and 
diazepam (3.0 mg/kg) caused decreases in responding at the 
lowest shock intensities, resulting in the increased 
median shock levels. 
Criticisms of this method include the confounding of 
a drug•s effect on response rate with its analgesic 
properties, and the use of shock as the aversive stimulus. 
Shock intensity is extremely difficult to control because 
of changes in subject's resistance and conductivity at 
electrical contact points. In addition, the shock 
sensation may become a conditional stimulus for avoidance. 
A drug's effect could then be due to changes resulting 
12 
from learning, or effects on tactile sensitivity, as well 
as on central antinociceptive activity. 
~illigan and Kallman (1963) were the first to use an 
aversive stimulus .as a discriminative cue. By using shock 
as a cue for availability of reward they hoped to prevent 
it from acquiring conditional avoidance properties at low 
intensities. Rats were rewarded for lever pressing if 
responses followed 
period. This is 
a shock presentation within a limited 
a "go no-go" paradigm in which the 
presence of the aversive .stimulus underlies the dependent 
measure of a go or no-go response. Morphine dose and 
shock level were varied. Morphine administration enabled 
the . subjects to perform better at higher shock 
intensities. However, many - more responses occurred 
outside of the correct response period. In this case a 
stimulant or disinhibiting action of a drug interferes 
with the subjects• ability to perform the task. Also, the 
problems inherent in the use of shock as the aversive 
stimulus are present. Since detection of the presence of 
shock was the positive discriminative stimulus for "when" 
to respond, the subject is likely to become sensitive to 
. electrical stimulation whether or not it is perceived as 
aversive. The 
during training, 
shock is always paired with reinforcement 
and this could result in its acquiring 
secondary reinforcing properties and corresponding 
reduction in perceived aversiveness. 
13 
Summary of Operant Methods 
Present operant behavioral methods for assessing 
analgesic properties of drugs _ have focused on shock as the 
aversive stimulus, and have used tasks where analgesic and 
gross response rate effects may become confounded. What 
is learned may not be reflected in what is measured so 
that interpretation of a drug's effect on the observed 
behavior is innacurate. Seldom have the same authors 
compared the effect of a drug on both operant and 
reflexive behavior induced by an aversive stimulus. An 
effective operant approach would ideally be able to 
separate analgesic Froperties of a drug from its effects 
on response rate. At the same time, it would not utilize 
a relationship between the aversive stimulus and reward or 
punishment that could alter the perceived aversive 
qualities of the stimulation. A modified discriminative . 
task similar to that of Milligan and Kallman could avoid 
these criticisms. 
14 -
The Proposed Model 
Aversive stimulation is readily discriminated by 
humans in most situations. We usually describe pain both 
in terms of its presence or absence, and in terms of its 
intensity. The use of peripherally induced aversive 
stimulation as a discriminative cue in laboratory animals 
provides the opportunity for objective measurement of a 
subjective state. Milligan and Kallman attempted this, 
but in a task which did not allow for a clear 
interpretation. If the subjects were given a choice of 
"where" to respond, rather than "when" to respond, several 
improvements in the Milligan and Kallman procedure would 
result. 
According to this procedure, a subject is confronted 
with two manipulanda, and a single receptacle for delivery 
of reward. The presence of the aversive stimulus is the 
cue for reinforcement of responses on one lever, and the 
absence of the stimulus is the cue for availability of 
reward for responses at the other lever. A fixed ratio 
schedule of reinforcement coupled with a counterbalanced 
treatment schedule allows the observer to determine when, 
how accurately, and how quickly the taslc is learned. All 
responses which occur prior to reinforcement are based on 
the subject's expectancy of location of availability of 
reward. The discriminative stimulus can be seen to have 
gained control of location of responding when the first 
15 
non-reinforced responses on successive daily trials occur 
consistently on the appropriate lever, even when the two 
discriminative treatments follow a randomized or 
counterbalanced order. 
The technique has been used to determine subjectively 
discriminable effects of internal, drug induced stimuli, 
including narcotic analgesics (Colpaert et al. 1975a; 
Shannon and Holtzman, 1976; Rosecrans et al. 1973; Lal et 
al • . 1977), aspirin (Wiessman,1976}, and certain 
peripheraly acting drugs (Colpaert et al. 1975b). Just 
as external auditory or visual stimuli can se~ve as 
discriminable stimuli, internally produced effects of 
stimulants, depressants, and narcotics can serve a similar 
function. Learning a response selection based on drug 
cues occurs at about the same rate as for a discrimination 
based on external, physical stimuli (Overton, 1971). 
Generalization between drugs of similar classes, and 
within the same drug at different doses, parallel similar 
manipulations of external discriminative stimuli 
(Barry, 197 4) • 
The use of an internal, chemically induced aversive 
stimulus in the above procedure could provide valuable 
information about drug effects on the discriminability of 
the stimulus, and basis of the discrimination. By using a 
two choice discriminative task the response rate and 
analgesic effects of a particular drug could be separated. 
16 
The choice of the "pain" appropriate lever as opposed to 
the "non-pain" lever, provides an assessment of analgesic 
efficacy when a drug is used to challenge the aversive 
stimulus. That the basis of the discrimination is the 
aversive quality of the stimulus, rather than its physical 
sensory characteristics, can be established by 
administering a known analgesic in conjunction with the 
aversive stimulus. If the analgesic does not interfere 
with sensory qualities, as with narcotic analgesics, but 
causes the subjects to respond on the "non-pain" lever, 
this is an indication that the discrimination is based on 
the subjective aversiveness of the stimulus and not on its 
purely sensory qualities. In addition, the behavioral 
toxicity of the drug will be seen in the overall response 
rate, no matter which response is chosen. The qualitative 
and response rate effects of the drug are independently 
measured by this procedure. The dose-response function 
for analgesic activity can be expressed by the proportion 
of subjects responding on the "pain" appropriate lever at 
each dose administered. There is no opportunity for the 
subjects to become sensitized to lower levels of the 
stimulus since this is not differentially rewarded by an 
opportunity to avoid the stimulus. The aversive stimulus 
is only paired with availability of reward on fifty 
percent of the trials, and is thus less likely to incur 
alterations in aversiveness as a result of secondary 
17 
reinforcement effects. 
In summary, the method used in these experiments 
utilized food deprived laboratory animals who were taught 
to perform one response following injection of a chemical 
irritant, and another response when either saline or a 
handling treatment was administered. Discrimination of 
the stimuli produced by this chemical was challenged with 
several pharmacological treatments. This provided data on 
the ability of the subjects to act on the basis of 
discrimination of an aversive stimulus, and the ability of 
different drugs to interfere with, or substitute for, the 
stimulus. Administration of known analgesics provided 
information on the basis of the discrimination. 
Experimental Treatments 
Assay.....Q.L_phenyl-p-benzoquinone as a pain producing~gent. 
An injection 2-phenyl-1, 4-benzoquinone (PBQ) vas 
used as the means of inducing noxious stimulation. In the 
first experiment the abiliy of PBQ to produce a behavioral 
reaction in rats, that could be quantified and would be 
reduced in 
analgesic, 
a 
was 
experiments an 
discriminative 
dose-dependent 
studied. In 
manner by a known narcotic 
the second and third 
injection of PBQ was used to produce a 
stimulus to be evaluated as a subjective, 
18 
painful experience by challenging the stimulus with 
established analgesics and non-analgesics. PBQ was 
selected 
it is a 
as the means of inducing a noxious state because 
potent writhe inducing agent (Vander Wende and 
Margolin,1956; Siegmund et al. 1957), and this behavior is 
blocked by narcotic and non-narcotic analgesics (Siegmund 
et al. 1957). 
Control treatments 
In order to control for cutaneous stimulation and PBQ 
.volume effects that could play a role in writhing induced 
by PBQ, saline in a vclume equal to each PBQ treatment was 
injected and observed for its ability to produce a 
writhing response. Both saline injection and needle 
insertion were observed for their ability to substitute 
for a PBQ injection in the discriminative task. · In 
addition, haloperidol was administered to determine 
whether non-specific central nervous system stimulation 
could substitute for PBQ. Haloperidol was chosen because 
it has a long onset of action that provided for a large 
temporal separation 
(120 minutes), and 
between injection and test 
has no known analgesic or intrinsic 
pain producing properties. 
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Blockade of PBQ-induced behavior 
Morphine was selected as the prototypical analgesic 
for investigating tbe basis of PBQ writhing and 
discrimination. Effective morphine blockade of PBQ 
writhing and discrimination would suggest that these 
actions of PBQ are due to its ability to act as a painful 
stimulus. Blockade of morphine's effect by the narcotic 
antagonist, naloxone, was investigated to determine 
whether this action was narcotic specific. When this was 
established, other drug treatments were observed for their 
ability . to block, or interfere . with, PBQ-induced 
discrimination. Aspirin and morphine are the ~wo drugs 
most frequently used for relief of pain (Houde et al. 
1965), and are used in most investigations of the basic 
mechanisms of analgesia (Mayer and Price, 1976; Fuccella 
et al. 1977). Several other centrally acting drugs having 
one or more actions in common with morphine were also 
tested for their effect on choice performance under the 
PBQ condition of the discriminative task. These are 
listed below. 
Pentobarbital was chosen because it is a potent 
barbiturate central nervous system depressant without 
clinical analgesic efficacy, and may even produce pain in 
certain patients (Goodman and Gilman, 1975a) • Both 
positive (Weiss and Laties, 1961) and negative 
(Malis, 1962) analgesic indications were found for this 
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drug using shock titration. Chlordiazepoxide is an 
antianxiety compound of the benzodiazepine class, and a 
potent muscle relaxant (Goodman and Gilman, 1975b). 
Mc Connell (1962) found that chlordiazepoxide may act 
similar to morphine in shock titration. Amitriptyline is 
a tri-cyclic anti-depressant that is not generally 
considered to possess analgesic activity, but may reduce 
pain-related affective disturbances (Goodman and 
Gilman, 1975c; Halpern, 1974). Haloperidol can 
significantly increase the analgesic potency of morphine 
(Tulunay et al. 1976), presumably due to its ability to 
block the access of dopamine to post-synaptic receptor 
sites {Goodman and Gilman, 1975d). Haloperidol is 
primarily used as an anti-psychotic medication, and 
appears devoid of any analge~ic properties of its own 
(Goodman and Gilman, 1975d). Morphine is known to possess 
anti-anxiety and anti-depressant activity associated with 
euphoria, central nervous system depression, and blocks 
dopamine receptors in conjunction with analgesia (Goodman 
and Gilman, 1975e). 
Generalization of PEQ discrimination to other chemical 
irritants 
Histamine is a potent naturally occurring 
physiological agent that is released from cells upon 
21 
injury (Levis, 
stimulant and 
Gilman, 1975f) • · 
1927) It 
sub-dermal 
is a powerful smooth muscle 
irritant (Goodman and 
This drug was administered to determine the 
specificity of the stimulus produced by PBQ. Its 
substitution for PBQ in the discriminative task would be a 
further indication that the stimulus control is based on a 
subjective "painful" state. 
Summary 
The significance of this research lies in the use of 
an operant technique which provides for quantification of 
a subjectively perceived stimulus. A chemical irritant 
was observed for its ability to support discriminative 
responding in rats. Known analgesic drugs were used to 
demonstrate that a subjective "painful" experience, and 
not just peripheral stimulation, formed the basis of the 
discrimination. several centrally active, non-analgesic 
drugs were tested for their effects on the discrimination 
to evaluate its specificity and adequacy as a model for 
study of analgesic treatments. A peripheral pain 
producing chemical was tested for generalization with the 
discriminative stimuli produced by PBQ; the experimental 
aversive stimulus. 
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Experiment 1 
Assessment of Phenyl-p-benzoquinone induced Writhing 
and its Antagonism by Morphine 
Introduction 
Prior to evaluation of PBQ as a discriminative 
stimulus, its ability to induce writhing in rats and the 
effect of a narcotic analgesic on this behavior was 
investigated. Several doses of PBQ were administered 
alone and following pretreatment with morphine, to 
establish dose-dependent effects of PBQ induced writhing, 
and morphine blockade of the writhing syndrome. This was 
done to verify PBQ activity as a model of aversive . 
stimulation able to be reduced by a known analgesic. 
Methods 
Twelve male, Long-Evans rats were obtained from 
Charles-River Breeding Company, Wilmington, Mass. At the 
beginning of the experiment they weighed 300 to 335 grams. 
All rats were housed singly in a thermostatically 
controlled environment with a 12 hour dark-light cycle. 
Food and water were available at all times in the 
subject's home cages. 
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Drug~ 
Phenyl-p-benzoquinone (PBQ) solution was prepared 
freshly each day by dissolving the appropriate weight in 
two milliliters of pure alcohol, and adding this solution 
to a volume of distilled water heated to 50°c. 
Morphine sulphate solution was prepared as needed by 
dissolving morphine sulphate in physiological saline to 
the desired concentration. Saline was prepared at 0.9% by 
adding sodium chloride to distilled water, and was kept in 
quantity. 
Behavioral observations 
Immediately after injection with either PBQ or 
saline, each rat was placed in a clear plexiglas container 
and observed for frequency of writhing for 30 minutes. A 
writhe was defined as "intermittent contraction of the 
abdominal muscles with extension 0£ the hind legs and 
twisting of the trunk", after Siegmund et al. (1957). The 
presence of all of these components was necessary for a 
response to be recorded as a writhe. An animal had to 
return to a normal posture before another writhe could be 
recorded. No more than three animals were observed by a 
single scorer at any one time. The observations were 
carried out in exactly the same manner when effects of 
morphine on PBQ writhing were observed. Morphine was 
administered 15 minutes prior to PBQ. 
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Experimental Procedure 
To observe the effect of intraperitoneal injection of 
PBQ, the group of 12 rats was initially divided into two 
groups of six subjects. One group received 1.~5 mg/kg 
PBQ, and 5.0 mg/kg was administered to the remaining 
subjects. The following day 10.0 mg/kg PBQ was 
adminstered to all 12 subjects. For the next two days, 
the corresponding volumes of physiological saline were 
injected to observe the effects of the PBQ vehicle. 
First, the 12 subjects were randomly divided into two 
groups of six. One group was given 1.25 ml/kg, and the 
second group 5.0 ml/kg. These were equivalent volumes to 
PBQ doses of 1.25 and 5.0 mg/kg. Two subjects from each 
of these groups (a total of four) were tested with 
10.0 ml/kg saline the following day. The experimental 
design can be seen in Table 1. 
Effect of morphine pretreatment 
To determine the effect of a narcotic analgesic on 
PBQ induced behavior, morphine sulphate was injected I. P. 
15 minutes prior to PBQ in a sequence of tests. Log doses 
of 1.25, 2.5 and 5.0 mg/kg were administered to all 
subjects in counterbalanced order, as seen in Table 2. 
E££ect 0£ repeated PBQ administration 
A dose of 10.0 mg/kg PBQ was administered to four 
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TABLE 1 
Experimental Treatment Schedule for Assay of 
PBQ-induced Writhing 
Day Subject Dose Drug 
1 
2 
3 
4 
1 - 6 
7 - 12 
1 - 6 
7 - 12 
1 - 6 
7 - 12 
3,6,9,12 
1.25 mg/kg 
5.00 mg/kg 
10.00 mg/kg 
10.00 mg/kg 
1.25 ml/kg 
5.00 ml/kg 
10.00 ml/kg 
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PBQ 
PBQ 
PBQ 
PBQ 
Saline 
Saline 
Saline 
1 
2 
TABLE 2 
Dose1 Schedule for Determination of the 
Effect of Morphine on PBQ-induced Writhing 
1 
DAY 
2 3 
3 - 1.25 2.50 5.00 
4 
1 
1 
1 
5 
6 
7 
8 
9 
0 
1 
2 
2. 50 5.00 1.25 
5.00 1.25 2.50 
1 Mg/kg injected I .P. 30 minutes prior to the 
Writhing observation period. 
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subjects for six successive days to investigate the 
possibility of tolerance to the behavioral effects of PBQ. 
The four subjects were randomly selected from the original 
group of 12 subjects. 
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Results and Discussion 
Intraperitoneal injection of PBQ in doses of 1.25, 
5.0 and 10.0 mg/kg produced dose dependent writhing. The 
data are presented in Table 3 and Figure 1. A linear 
regression analysis yielded a correlation coefficient of 
0.998, and a significant analysis of variance value for 
the regression (F,df1,1=332, P < 0.035). An analysis of 
variance performed on the . mean frequency of writhing for 
each dose also produced a significani F value 
(F,df1,8=8.41, P < 0.01). A follovup Tukey test indicated 
that the mean writhing frequency induced by 10~0 mg/kg PBQ 
vas significantly different from that produced by 
1.25 mg/kg (T df15=19, P < 0.01) • . The only significant 
difference in writhing was between these two doses of PBQ. 
Although the writhing levels of 10 mg/kg compared to 
5 mg/kg, and 5 mg/kg compared to 1.25 mg/kg appear quite 
large, the equally large variability in writhing frequency 
for individual subjects resulted in an inability to attain 
statistical significance between these groups with the low 
number of subjects utilized. 
The data show that PBQ injection results in 
dose-dependent writhing in hooded rats. That the .writhing 
response is due entirely to the action of PBQ, and not the 
injection procedure or fluid volume, is demonstrated by 
the failure of injection of similar volumes of 
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TABLE 3 
A Comparison of Writhing Produced by PBQ or Saline 
1 Frequency oi Drug Dose N Writhing 
PBQ 1.25 6 3 + 1.3 
PBQ 5.00 6 13 + 6.6 
PBQ 10.00 12 22 + 4.4 
Saline 1.25 6 0 + 0 
Saline 5.00 6 0 + 0 
Saline 10.00 4 0 + 0 
1 Mg/kg of PBQ, and ml/kg saline; both injected I.P. immediately 
prior to observation. 
2 Mean+ standard error for a 30 minute observation period. 
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Figure l 
Dose Response for PBQ - Induced Writhing in Hooded Rats 
The Y axis represents writhing frequency. Mean writhing 
frequency+ standard error is plotted for 6 subjects at 1.25 
and 5.0" mg/kg doses of PBQ (given I.P. immediately before a 30 
minute observation period) and 12 subjects at 10.0 mg/kg PBQ. 
PBQ doses are shown on the X axis. 
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physiological saline to induce any writhing whatsoever 
(see Table 3) • 
When morphine was administered 15 minutes prior to 
10.0 mg/kg PBQ, dose-dependent blockade of the writhing is 
seen, as shown in Table 4 and Figure 2. The correlation 
coefficient for the computer plotted best fitting linear 
function was 0.99 for dose vs. mean writhing level on the 
X and Y axes, respectively. An analysis of variance 
performed on the regression was significant (F 
df1,1=176.4, P < 0.05). An analysis of variance for 
comparison of mean writhing levels for the three doses of 
morphine was also significant (F ·df2,18=3.52, . P < 0.05). 
A Tukey followup analysis found a significant difference 
between doses of 5.0 mg/kg and 1.25 mg/kg only (T df22=15, 
P < 0. 05) • 
Writhing frequency remained at a high level when PBQ 
was injected once per day for 6 consecutive days (refer to 
Table 5 and Figure 3). The regression coefficient for 
comparison of total writhing frequency vs. days was 0.56. 
The analysis of variance for the regression was 
non-significant ' (F df1,4=14.8, P > 0.05), as was an 
analysis of variance performed on the 6 mean daily 
writhing frequencies ~ dfS,18=0.57, P > 0.05). 
It was concluded that PBQ administration is effective 
in producing a behavior which may be interpreted as 
pain-related since a known analgesic, morphine, blocks the 
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TABLE 4 
Effect of Morphine 1on PBQ~induced Writhing 
Dose (mg/kg) 
0 
1.25 
2.50 
5.00 
Frequency 3of Writhing 
22 + 4.4 
15 + 5.4 
9 + 4.5 
0 + 0 
1 Injected I.P. 30 minutes prior to observation. 
2 10 mg/kg I.P. immediately before observation. 
3 Mean+ standard error for a 30 minute observation period. 
Each ;alue represents 12 subjects. 
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Figure 2 
Effect of Morphine on PBQ - Induced Writhing 
PBQ - induced writhing was observed for 30 minutes after 
pretreatment with morphine. The mean+ standard error of writhing 
frequency was plotted for each dose of morphine. Morphine doses 
were given I.P. 30 minutes prior to observation in all 12 subjects 
in counterbalanced order, and are s.hown on the X axis. Writhing 
frequency is shown on the Y axis. 
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TABLE 5 
PBQ!induced Writhing during Chronic Administration 
Day 
Frequency ~f 
Writhing 
1 13.50 + 1.6 
2 11.25 + 2. 7 
3 10.25 + 1.25 
4 9.00 + 4.3 
5 12.75 ' + 2.2 
6 8.75 + 2.2 
1 10 mg/kg I.P. 
2 Mean+ standard error for a 30 minute observation period. 
N = 4 for each value. 
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Figure 3 
Frequency of Writhing during Chronic PBQ Treatment 
PBQ at 10.0 mg/kg was administered once per day for 6 days 
(X axis} to determine whether significant tolerance to PBQ writhing 
would develop. The total frequency of writhing (Y axis) is plotted 
for the group for each of the 30 minute observation periods. 
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writhe inducing action of FBQ in a dose-related manner. 
Based on this, it was concluded that PBQ would be an 
effective stimulus in a discriminative operant task. 
Maintenance 
treatment 
subjective 
basis of 
processes. 
of a discrimination of PBQ from an alternate 
would provide for determination of the role of 
aversive attributes of the stimulus as the 
the discrimination, and as a model of pain 
This was investigated in Experiments 2 and 3. 
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Experiment 2 
Evaluation of PBQ Administration 
as a Discriminative Stimulus 
Introduction 
Following assessment of PBQ induced writhing and its 
blockade by morphine pretreatment, the ability of PBQ 
administration to serve as a discriminative stimulus vas 
studied. In the first experiment PBQ and saline 
injections served as the two conditions to be 
discriminated. 
Methods 
Subjects 
Male rats of the Long-Evans strain weighed 300 to 340 
graas at the beginning of the experiment. The 20 subjects 
vere housed as in Experiment 1. Water was available at 
all times in the home cages, but food was limited so that 
the animals were maintained at 80% of free feeding body 
weights. 
Procedure 
The subjects were trained to lever press for food 
(Noyes 45 mg pellets) on each of two levers mounted on one 
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wall of standard operant chambers. The food receptacle 
was located between the levers and was equidistant from 
each. Discrimination training and shaping of fixed ratio 
performance were carried out simultaneously. Responding 
on one of the two levers was reinforced after an injection 
of 1.25 mg/kg PBQ given 5 minutes before each trial. The 
opposite lever produced reinforcement following an 
injection of saline at the same injection-trial interval. 
Assignment of PBQ correct lever position for each subject 
was randomized, and PBQ or saline treatments were 
counterbalanced according to the following tvo sequences: 
PBQ s s - PBQ - sand PBQ - PBQ - s - PBQ - s - s. 
These sequences were presented in randomized order with 
the stipulation .that no treatment was ever given more than 
twice in succession. Trials were carried out once a day 
at least 5 days per week, and were of 10 minutes duration. 
Total reinforcements, total incorrect responses, and 
incorrect responses occurring prior to the first 
reinforcement, were recorded for each subject for each 
trial. 
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Results and Discussion 
PBQ toxicity 
The experiment was carried out for a total of 90 
trials. During this period 16 of the original 20 subjects 
were discontinued. Death was the cause in 6 subjects. 
The other 10 became ill, lost weight, and would not 
respond when placed in the operant chambers. This 
indicates that the dose of PBQ used for training was quite 
toxic, causing peritcneal inflammation and infection with 
swelling of the gut and loss of task performance in a 
majority of the subjects. 
Discrimination performance 
An analysis of the trial by trial data shows that 7 
of the 20 subjects reached the level of performance that 
was considered indicative of reliable learning of the 
task. This is 8 out of 10 consecutive trials for which 9 
or fewer responses occurred on the "wrong" lever prior to 
the first reinforcement on that trial. The mean number of 
trials for reaching this criterion was 49±8, with ' 20 being 
the least, and 80 t -he greatest number of trials required 
to reach the criterion. The mean number of trials correct 
for each 10 trials after reaching criterion was 6.5±4, 
indicating that maintenance of the task was relatively 
unstable. An examination of the data suggests that much 
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of this instability was due to behavioral toxicity of the 
PBQ, as the decline in accuracy generally preceded illness 
or death of the subject. However, response rates on PBQ 
and saline trials did not significantly differ when an 
average of trials 10 through 30 (the first 10 trials for 
each treatment) were taken for each subject and compared 
for the _group by means of a dependent t test (PBQ=774±45, 
saline=803±68, t df18=0.59, P > 0.05). 
Analysis of the group data also shows that 
significant learning cccurred for the group as a whole. A 
regression analysis of the number correct in each ·of the 9 
blocks . of 10 trials demonstrated that the increase in 
correct trials over days is a linear function for the 
group (r=0.82, F df1,7=14.8, P < 0.006). 
presentation of the data see Figure 4. 
Summary 
For a 
The data of this experiment show that PBQ 
administration can be discriminated from a saline 
injection, since seven subjects attained a rigorous 
criterion performance, and the group as a whole improved 
sigificantly in overall performance. 
Although this is a conclusive demonstration that 
PBQ-saline discrimination can be acquired, the performance 
is not 0£ sufficient reliability to provide a behavioral 
baseline for a model to evaluate analgesic treatments. 
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Figure 4 
Acquisition of PBQ - Saline Discrimination 
Performance· during acquisition of PBQ - saline discrimination 
is presented as the mean+ standard error of correct lever selections 
(Y axis) in each 10 day period (X axis) during the course of the 
experiment.. One 10 minute trial was given per day, preceded by 
either a PBQ or saline injection (I.P.) 5 minutes before the trial. 
Correct lever selection was defined as 9 or fewer responses on the 
incorrect lever before the first 10 responses were completed on the 
lever appropriate for that day1 s injection treatment (either PBQ 
or saline). 
45 
IO
 
9 
t3
 
0 s 
8 
~ ti 
7 
p.
. 
E-
i 
u
 
~
 
i 
6 
°
' 
u
 ti 
5 
I ; 
4 3 
1/
/ 
I 
I 
I 
I 
I 
•
 
10
 
30
 
50
 
70
 
90
 
A
CQ
UI
SI
TI
ON
 TR
IA
L 
B
LO
CK
 
Discrimination of centrally acting drugs, such as 
narcotics and barbiturates, is maintained at an extremely 
high level of accuracy (Colpaert et al. 1975; Lal et u_. 
1977). There are two likely explanations for the low 
level of accuracy in the present experiment. The first is 
tissue damage accompanied by loss of ability to detect the 
stimulus. This is equivalent to a constant, high level of 
irritation which developes with chronic PBQ treatment and 
prevents discrimination of the acute PBQ stimulus on those 
test trials. However, some subjects continued to perform 
without noticeable illness for long periods during which 
accuracy for discrimination fluctuated to a great degree; 
from 3 to 10 out of 10 correct in one instance of 20 
consecutive trials. This may be explained by the 
existence of masking irritation which developed during 
certain periods and prevented accurate performance on PBQ 
or saline trials. 
A second possible . cause for difficulty in task 
acquisition is that the saline injection, in itself, may 
produce significant irritation making the PBQ - placebo 
discrimination difficult. 
Two experimental task modifications were introduced 
in the third experiment to minimize detrimental effects of 
these possible compllcations and optimize discriminability 
of the PBQ and non-PBQ conditions. First, the dose of PBQ 
was lowered to 0.62 mg/kg. This was done in order to 
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reduce the chance of tissue damage and development of 
chronic irritation with repeated PBQ administration during 
training. Secondly, the saline treatment that was 
alternated with PBQ as the treatment to be discriminated, 
was discontinued. The advantage sought was increased 
distinctiveness of the PBQ from non-PBQ treatment. On the 
alternating non-PBQ trials the animals now received only a 
handling treatment. A major problem with this procedure 
was that the injection could become a significant 
component of the discrimination in addition to PBQ induced 
stimuli. This possibility was accepted for two reasons: 
1.). When PBQ discrimination was attained to a _high level, 
saline could be injected on certain test sessions to 
determine the role of the injection procedure in the 
discrimination 2.) If the injection procedure was a 
significant component of the discriminative stimulus, it 
could also be evaluated as a model of pain itself. 
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_uperiment 3 
. 
Characterization of a Discrimination 
based on PBQ Treatment 
Introduction 
In Experiment 2 it was demonstrated that PBQ and 
saline administration will acquire differential stimulus 
control of behavior. This control was of a low degree of 
accuracy, possibly due to the similarity between PBQ and 
saline treatment. In this experiment conditions were 
optimized for discriminability of PBQ from the non-PBQ 
treatment. When a criterion for discriminative 
performance was acheived by each subject, several 
experimental and control treatments were applied on 
certain trials to determine the adequacy of PBQ 
discrimination as a model of pain for the study of 
analgesic treatments. 
Methods 
A total of 49 male, Long-Evans rats were employed. 
They were housed as were the subjects in Experiment 2. 
Procedure 
Magazine training and shaping to respond on an FR10 
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schedule for food reinforcement in dual lever operant 
chambers was carried out as in Experiment 2. 
Discrimination training was carried out as in Experiment 2 
except that saline injections were not administered. The 
subjects were trained to discriminate a PBQ injection from 
handling without injection, according to the same schedule 
. of counterbalanced treatments. The dose of PBQ was 
0.92 mg/kg. 
When a criteri .on vas reached of not more than 9 
responses on the incorrect lever for 8 out of 10 
consecutive trials, the following experimental and control 
treatments were applied (for details of dose and 
injection-test interval for each drug see Table 6). The 
order of drug and dose testing was counterbalanced (for 
details see Appendix 1). 
Control 
of diff e:ren t 
selection was 
injected, or 
minutes prior 
and generalization treatments. The ability 
treatments to produce PBQ appropriate lever 
tested in the absence of PBQ. Saline was 
a needle . inserted without 
to testing to determine 
injection, 
whether the 
5 
injection procedure or vehicle volume would be perceived 
as PBQ treatment. On some test trials 0.62 and 0.16 mg/kg 
PBQ were 
effects. 
.administered 
Haloperidol 
for observation of dose-response 
was injected on other test days to 
observe whether the effect of a centrally acting drug 
would be perceived as PBQ or non-PBQ treatment, to 
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establish the stimulus specificity of PBQ. In addition, a 
known chemical irritant (histamine) was injected 
intraperitoneally. This substance is reported to be a 
potent pain producing agent. Its ability to produce PBQ 
appropriate responding was investigated to determine if 
the subjective stimuli produced by the drug are similar to 
that of PBQ. 
Experimental treatments. Morphine and aspirin were 
administered prior to PBQ treatment to determine whether 
narcotic and non-narcotic analgesics antagonize PBQ 
treatment discrimination. Other non-analgesic, centrally 
acting drugs were administered on certain PBQ trials to 
evaluate the specificity of antagonism of PBQ treatment 
discrimination. 
Four subjects were administered 10 mg/kg PBQ at the 
conclusion of the experiment, and writhing behavior was 
observed for 30 minutes. This provided an indication of 
the effect of the chronically administered 0.62 mg/kg 
training dose on sensitivity to the PBQ action. The 
subjects each had at least 50 prior PBQ treatments. 
Five additional subjects were injected with 1.0 ml/kg 
saline and observed for writhing for 30 minutes. If the 
injection procedure had become a conditional stimulus for 
PBQ treatment able to elicit writhing by virtue of 
pairings with PBQ treatment, this cou1d be detected. 
51 
Results and Discussion 
Task acquisition and EBO toxicity 
Of the 49 subjects utilized, 26 completed the 
experiment, 7 died during the course of the study, and 16 
were discontinued due to illness which interfered with 
performance. Criterion performance was reached by 26 of 
the 49 subjects in a mean of 58±6 trials. The fewest 
number of trials required for attaining the criterion 
level was 16, and 116 trials the most. As in Experiment 
2, there was no significant difference between PBQ and 
non-PBQ trials for mean response rate levels (mean for 
saline trials 10 through 20=774±40, and 769±33 for PBQ 
trials \'10 through 20 for the 26 subjects reaching 
criterion, t df52=0. 20, P > O. 05). 
Comparing these data to those of Experiment 2, it is 
clear that a PBQ injection is discriminated from a non-PBQ 
treatment. Learning of the task took place at a 
comparable rate in both experiments (49±8 trials to 
criterion in Experiment 2, and 58±6 trials in Experiment 
3), although the dose of PBQ used in Experiment 3 was half 
of that used in Experiment 2. The acquisition data are 
presented in Figure 5. A higher proportion of the total 
. number of subjects used actually acquired the 
discrimination in Experiment 3 (26/49 or 53%) as compared 
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Figure 5 
Acquisition of PBQ Treatment Discrimination 
The cumulative percentage of the total number of subjects 
(26) who acquired the PBQ - No treatment discrimination in 
Experiment 3 is plotted for each block of 10 trials until the 
final subject attained the criterion. 
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to Experiment 2 (7/20 or 35%}. This difference was not 
significant as determined by X1 analysis (:rdf1=1.89, P > 
0.05). Also, only 5 of the 20 animals who originally 
began Experiment 3 completed more than the initial 90 
trials. This indicates that the discrimination of 
Experiment 3 can be acquired by more subjects than that of 
Experiment 2, but it is not learned faster, nor is the PBQ 
treatment less toxic even though the dose is half as 
large. 
PBQ dose-response and generalization tests 
When criterion performance was reached, doses of O, 
0.16, or 0.62 mg/kg of PBQ were administered on certain 
test trials to 10 subjects at each dose according to the 
counterbalanced treatment schedule seen in Appendix 1. 
The data, shown in Table 7 and Figure 6, demonstrate that 
the dose response for PBQ discrimination in this 
experiment is linear (r=0.983, F df1,1=361, P < 0.05). 
All percentage data were transformed to a common 
logarithmic value prior to regression and analysis of 
variance computation. The EDSO for PBQ discrimination was 
0.26 mg/kg Administration of a saline injection to 20 
subjects produced PBQ treatment responding in 8 animals, 
or 40% of the total number tested, as shown in Table a. 
This proportion was significantly different from that 
found either for no-treatment (r'df1=10, P < 0.01) or for 
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TABLE 6 
', 
Summary of Test Treatments for Experiment 3 
2 Response Treatment-Test 1 Lever Choice Rate Drug Dose PBQ/Total Mean+ S.E. Interval (min.) 
None 0/20 774+40 5.0 
Saline Injection 1.00 8/20 914+58 5.0 
Saline Injection 1.00 6/12 997+93 30.0 
Needle Insertion 5/10 816+81 5.0 
PBQ 0.62 20/20 769+33 5.0 
PBQ 0.62 9/12 999+99 30.0 
PBQ 0.16 5/10 83o+78 5.0 
Histamine 1.25 6/6 807+65 5.0 
Morphine+ 10.00 30.0 
PBQ 0.62 0/5 192+45 5.0 
Morphine+ 5.00 30.0 
PBQ 0.62 1/5 752+136 5.0 
Morphine+ 1.25 30.0 
PBQ 0.62 4/5 762+184 5.0 
Morphine+ 5.00 30.0 
Naloxone + 1.25 10.0 
PBQ 0.62 5/5 846+88 5.0 
Amitriptyline + 40.00 60.0 
PBQ 0.62 2/3* 171+85 5 . 0 
Amitriptyline + 20.00 60 . 0 
PBQ 0.62 5/6 585+160 5.0 
Amitriptyline + 10.00 60.0 
PBQ 0.62 3/6 65o+36 5.0 
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TABLE 6 Continued 
2 Response 
1 Lever Choice Rate Treatment-Test Drug Dose PBQ/Total Mean+ s.E. Interval (min.) 
Amitriptyline + 5.00 60.0 
PBQ 0.62 5/6 953+126 5.0 
Pentobarbital + 20.00 20.0 
PBQ 0.62 6/10 304+89 5.0 
Pentobarbital + 10.00 20.0 
PBQ 0.62 4/10 703+112 5.0 
Pentobarbital + 2.50 20.0 
PBQ 0.62 6/10 971+86 5.0 
Pentobarbital + 10.00 20.0 
No Treatment 5/8 . 328+117 5.0 
Haloperidol + 0.32 120.0 
PBQ 0.62 5/5 316+64 5.0 
Librium+ 10.00 30.0 
PBQ 0.62 4/5 366+35 5.0 
Aspirin+ 740.·oo 45.0 
PBQ 0.62 2/6 567+27 5.0 
Aspirin+ 160.00 45.0 
PBQ 0.62 2/6 653+125 5.0 
Aspirin+ 40.00 45.0 
PBQ 0.62 3/6 692+80 5.0 
Aspirin+ 10.00 45.0 
PBQ 0.62 4/6 782+98 5.0 
HaloEeridol 0.32 1/6 43+17 120.0 
1 Mg/kg of body weight, except for saline, which was given in ml/kg. 
2 Proportion choosing the the PBQ lever of all subjects tested. 
* Only 3 of the 5 subjects tested at this dose were able to respond. 
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TABLE 7 
Dose Response for PBQ Discrimination 
1 Dose 
o.oo 
0.16 
0.62 
N 
20 
10 
20 
% Responding 
on Drug Lever 
0 
50 
100 
1 Mg/kg I.P. 5 minutes prior to test. 
2 Mean+ standard error for a 10 minute 
58 
2 Response Rate 
774 + 40 
830 + 78 
769 + 33 
response period. 
Figure 6 
Dose Response for PBQ Discrimination 
Either 0, 0. 16, or the training dose of 0.62 mg/kg PBQ (doses 
of PBQ are found on the X axis) was administered I.P. 5 minutes prior 
to a discrimination test trial. The percent of total subjects 
tested (20 at 0, 10 at 0.16, and 20 at 0.62) who selected the PBQ-
appropriate lever for responding can be found on the Y axi~ 
(a) denotes PBQ lever selection 5 minutes after a saline injection in 
20 subjects. 
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g) 
Treatment Dose 1 
Saline 1.00 
Needle 
Insertion 
Haloperidol 0 . 32 
Histamine 1.25 
1 Ml/kg for saline, 
conditions. 
TABLE 8 
Tests of Several Treatments for 
Generalization with PBQ Stimuli 
% Responding 
N on Drug Lever Response Rate 
20 40 914+58 
10 so· 816+81 
6 17 43+12 
6 100 807+65 
mg/kg for all others; injections were I .P . 
2 Mean+ standard error for a 10 minute response period. 
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for all 
a dose of o.62 mg/kg PBQ (X'J.df1=17.1, P < 0.01), but was 
not significantly different from the effects of 0.16 mg/kg 
PBQ ex~ df1=0.27, P > 0.05) or needle insertion alone; 
which produced drug lever responding in 5 of 10 subjects 
tested. This indicates that a hypodermic needle insertion 
by itself, can produce . significant responding on the PBQ 
treatment lever, but does not substitute completely for 
the training dose of PBQ. 
Injection of PBQ or saline 30 minutes prior to a test 
trial produced a decrease in the discriminability of PBQ, 
but not the saline treatment (see Table 6). 
Administration cf the antipsychotic, dopaminergic 
blocking agent haloperidol 2 hours prior to a test trial 
produced PBQ appropriate responding in only one of six 
subjects tested (refer to Table 8). This was not 
significantly different from no-treatment by chi-square 
analysis (X~ df1=3.41, P > 0.05), although re~ponding was 
severely depressed when compared with baseline values for 
no-treatment (F df1,5=25.81, P < 0.01). 
Injection of histamine at 1.25 mg/kg to 6 subjects 
elicited PBQ-treatment responding in all of them, without 
affecting response rate (t df10=1.22, P > 0.05). A 
summary of these data is presented in Table 8. 
Table 9 shows the number of responses made on the 
non-selected lever for experimental and control tests. 
These values indicate the mean strength of choice for all 
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TABLE 9 
Strength of Choice as Indicated by the Mean 
Number of Responses on the Non-Selected Lever . 
Shown for Subjects Selecting either the PBQ or 
No-Treatment Lev~r for Responding after each Test. 
PBQ Responses on No-Treatment Responses on 
1 Selectin 2 Alternate Selectinf Alternate Treatment Dose Subjects Lever3 Subjects Lever 2 
None 0 ------- 20 1.6+0.6 
Saline 
Injection 1.00 8 1.1+1.0 12 2.7+o.9 
Saline+ 
30 min. 1.00 6 1.6+1.2 6 1.2+o. 7 
Needle 
Insertion 5 3.8+2.0 5 4.o+2.0 
PBQ 0.62 20 1. 7+o.6 0 ------
PBQ + 30 mift. 0.62 9 2 . 8+1.3 3 1.9+o.9 
PBQ 0.16 5 
------- 5 3.4+1. 7 
Histamine 1.25 6 1.8+1.0 0 -------
MorpI,ine + 10.00 
PBQ 0.62 0 ------- 5 4. 2+1. 8 
Morphine+ 5.00 
PBQ 0.62 1 6.o+6.0 4 1.o+o.7 
Morphine + 1.25 
PBQ 0.62 4 0.8+0.8 1 4.o+4.0 
Morphine+ 5.00 
Naloxone + 1.25 
PBQ 0.62 5 5 . 4+2.2 0 ------
Amitriptyline+40.00 
PBQ 0.62 2 1.o+l.0 1 9.o+9.0 
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TABLE 9 Continued 
PBQ Responses on No-Treatment Responses on 
1 Selectin~ Alternate Selecting Alternate Treatment Dose Subjects Lever3 Subjects4 Lever2 
Amitriptyline + 20.00 
PBQ 0.62 5 2.8+1. 7 1 9.o+9.0 
Amitriptyline + 10.00 
PBQ 0.62 3 l.o+l.O 3 4.3+2.4 
Amitriptyline + 5.00 
PBQ 0.62 5 1.4+1.0 1 -------
Pentobarbital + 20.00 
PBQ 0.62 6 Lo+0.5 4 -------
Pentobarbital + 10.00 
PBQ 0.62 4 0.3+o.3 6 0.5+0.5 
Pentobarbital + 2.50 
PBQ 0.62 6 3,0+1.4 4 7.8+o.6 
Pentobarbital + 10.00 
NO:..Treatment 3 ------- 5 2.4+0.9 
Haloperidol + 0.32 
PBQ 0 . 62 5 4.8+1. 7 1 7.o+7.0 
Librium+ 10.00 
PBQ 0.62 4 6.3+1.8 1 6.o+6.0 
Aspirin+ .:]40.00 
PBQ 0.62 2 0.5+0.5 4 2.6+1.5 
Aspirin+ 160.00 
PBQ 0.62 2 6 . o+l.O 4 5.3+1.9 
Aspirin+ 40.00 
PBQ 0.62 3 1.0+1.0 3 L 7+1. 7 
Aspirin+ 10.00 
PBQ 0.62 4 4.5+2.6 2 -------
Haloperidol 0.32 1 2.o+2.0 5 3.5+1.2 
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TAELE 9 Continued 
1 Mg/kg of body weight, except for saline, which was given in ml/kg. 
2 Total number of subjects selecting the PBQ lever for responding 
after the indicated test treatment. 
3 Mean responses (+ S.E.) which were emitted on the non-selected lever 
prior to 10 responses on the other lever. 
4 Total number of subjects selecting the no-treatment lever for 
responding after the indicated test treatment. 
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lever selections. Strength of choice is indicated by the 
level of responding on the non-selected lever by each 
subject prior to ccmpletion of 10 responses on the 
selected lever. Low values show that the subjects did not 
respond haphazardly until obtaining reward, but tended to 
complete all 10 responses on the lever selected. It is 
interesting that the values for subjects selecting the PBQ 
or no-treatment levers on control tests did not differ in 
this respect. A value of five or larger, however, may be 
indicative of a significant degree of uncertainty. The 
single PBQ selecting subject tested at 5.0 mg/kg morphine 
responded six times on the non PBQ lever before 
completing 10 responses on the PBQ treatment lever. A 
similar result is seen with 20 and 10 mg/kg amitriptyline 
treatments. Subjects selecting the no-treatment lever 
responded on the PBQ treatment lever an average of 9 times 
before completing their choice. Subjects selecting the 
no-treatment lever after 2.5 mg/kg pentobarbital completed 
a mean of 7.8 responses on the PBQ treatment lever first. 
The same pattern can be seen following pretreatment with 
haloperidol. Also, both librium and 1~0 mg/kg aspirin 
treatments produced large numbers of responses on the 
non-selected lever regardless of the final choice. It is 
of interest that pentobarbital treatment did not result in 
large numbers of responses on the non-selected lever, as 
might be predicted by a state dependent explanation of its 
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effect on choice behavior. In general, it appears that 
choice is made in a clear-cut fashion, and not at random. 
Effect of analgesics and other centrally acting drugs on 
discrimination of a PEQ injection 
Discrimination of the PBQ injection was observed 
following pretreatment with either morphine or aspirin on 
several test trials. A summary of the results can be seen 
in Table 6. A dose-dependent blockade of PBQ treatment 
discrimination is evidence that the basis of the 
discrimination involves both sensory and aversive 
affective components by which we define pa"in. The results 
which follow support this hypothesis. 
Morphine sulphate pretreatment prevented 
discrimination of the PBQ injection in a dose-dependent 
manner, as shown ~n Figure 7. Four of the 5 subjects 
pretreated with 1.25 mg/kg responded on the PBQ injection 
lever, while only one of the 5 subjects tested at 5 mg/kg 
did so. When 10 mg/kg morphine was given prior to PBQ 
treatment, all subjects chose the non-PBQ lever for 
responding. The correlation coefficient for the computer 
generated best linear function was 0.955, F df1,2=20.52, P 
< o.os. 
4.06 mg/kg. 
The EDS0 for blockade of PBQ discrimination was 
An analysis of variance indicated a 
significant effect of morphine on response rate 
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Figure 7 
Effect of Morphine Pretreatment on PBQ Discrimination 
Discrimination test trials were carried out 5 minutes after 
administration of the training dose of 0.62 mg/kg PBQ, following 
pretreatment 30 minutes earlier with either 0, 1.25, 5.0 or 10 mg/kg 
morphine sulphate (X axis). The percent of subjects tested at each 
dose (N = 5 at each dose) who selected the PBQ appropriate lever for 
responding can be found on the Y axis. 
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(F df3,16=5.89, P < 
non-linear (r=0.879, F 
0.01), although 
df 1 ,2=6. 08 9, P 
this 
> 
effect was 
0.05). The 
between groups variance was primarily accounted for by the 
response suppressing effects of the 10 mg/kg dose as 
compared with the others by a Tukey follovup analysis (P < 
O. 01 for 1 O mg /kg vs • . all other doses) • The 5 mg /kg dose 
did not affect response rate as compared to no treatment 
(P > 0.05, Tukey test) • . Morphine in combination with 
naloxone had no significant effect on the PBQ treatment 
discrimination, as shown in Table 6. 
The blockade of PBQ treatment discrimination by 
morphine, a narcotic analgesic, suggests that the 
discrimination is based on a painful experience. This 
experience includes both sensory and negative affective 
components. The analgesic action of morphine is 
considered to be largely due to its effect on the aversive 
emotional 
that this 
component of the painful experience, suggesting 
an important component contributing to the 
discriminatrion. 
To further evaluate the effect of commonly accepted 
analgesics on the EBQ treatment discrimination, aspirin 
was tested in the same manner as morphine. The five doses 
of aspirin employed ranged from Oto 740 mg/kg orally. 
A linear regression analysis of the common log 
transformation of the PBQ-aspirin dose response shows that 
the aspirin-discrimination relationship was non-linear 
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(r=o.70, F df1,3=9.58, P > 0.05). The calculated ED50 for 
aspirin blockade is 340 mg/kg. An analysis of variance of 
the effect of the doses on response rate shows a 
significant effect cf aspirin (F df3,20=4.03, P < 0.05). 
This was due to a significant difference between only two 
doses, 0 and 740 mg/kg aspirin (P < 0.01, Tukey Gap test). 
As seen in Figure 8, the blockade of PBQ treatment 
discrimination was not complete, even at the highest dose; 
unlike the action cf morphine. The greatest level of 
blockade was 67%. This action of aspirin appears to be a 
central effect, as the drug was administered orally. 
Doses which have been found to block PBQ-induced writhing 
differ for different investigat~rs, ranging from 165 mg/kg 
P. o. (Siegmund et u. 1957), to 750 mg/kg (Evans, 1975). 
It appears 
perception 
suppress it. 
that aspirin raises the threshold for 
of the PBQ treatment, but does not completely 
The effect of aspirin on PBQ treatment discrimination 
is further evidence that a central pain experience is the 
primary basis of the discrimination. However, the 
question 
whether 
remained after tests with morphine and aspirin 
the blockade of PBQ treatment discrimination is 
specific to analgesics, or whether other centrally acting 
drugs may show similar activity. To investigate this 
possibility several other centrally acting drugs not 
recognized as possessing analgesic activity were tested in 
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Figure 8 
Effect of Aspirin Pretreatment on PBQ Discrimination 
Discrimination test trials were carried out 5 minutes after 
administration of the training dose of 0.62 mg/kg PBQ following 
pretreatment 45 minutes earlier with either 0, 10, 40, 160 or 740 mg/kg 
aspirin given orally to 6 subjects at each dose. Aspirin doses can 
be found on the X axis. The percent of subjects tested at each dose 
who selected the PBQ appropriate lever for responding can be 
found on the Y axis. 
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the same manner as morphine and aspirin. 
Librium, a benzodiazepine muscle relaxant and 
anti-anxiety drug, did not effect discrimination of the 
PBQ treatment (Xz df3,=1.11, P > 0.05) at a dose which 
severely depressed the subjects• response rates (mean 
response rate for PBQ alone= 661 ± 100, and 366 ± 35 for 
librium pretreatment on PBQ test trials, F df1,8=7.823, P 
< 0.05). For a summary of the data see Table 6. 
A dose of 0.32 mg/kg haloperidol administered two 
hours prior to PBQ discrimination tests had no effect on 
lever selection, as ail 5 subjects tested responded on the 
PBQ treatment appropriate lever. At this dose response 
rates were suppressed to a mean level Of 316 ± 64 from 
baseline levels of 723±108, F df1,8=10.588, P < 0.05. 
Results of pretreatment with pentobarbital are less 
clear. The dose response curve generated from tests of 
PBQ treatment discrimination after pretreatment with 
several doses of pentobarbital was non-linear (F 
df1,2=9.891, P > 0.05), although the correlation 
coefficient was 0.86. Sixty percent of the ten subjects 
tested at 2.5 and 20 mg/kg (see Figure 9) responded on the 
PBQ treatment approfriate lever, and this was 
significantly different from baseline PBQ discrimination 
performance of 10 cut of 10 correct PBQ choices (x1 
df1=5.0, P < 0.05). At 10 mg/kg pentobarbital 6 of the 10 
subjects chose the no treatment lever for reinforcement. 
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Figure 9 
Effect of Pentobarbital Pretreatment on PBQ Discrimination 
Discrimination test trials were carried out 5 minutes after 
administration of the training dose of 0:62 mg/kg PBQ~ following 
pretreatment 20 minutes earlier with either 0, 2.5, 10 or 20 mg/kg 
pentobarbital given I.P. to 10 subjects at each dose. Doses of 
pentobarbital can be found on the X axis. The percent of subjects 
tested at each dose who selected the PBQ appropriate lever for 
responding can be found on the Y axis. 
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This is a significant difference from baseline performance 
of 10 out of 10 on the PBQ appropriate lever (X2 df1=8.58, 
P < 0.01). The 20 mg/kg dose of pentobarbital, a 
sedative-hypnotic central nervous system depressant, 
caused marked response suppression as seen in a 
significant analysis of variance (F df3,36=8.84, P < 
0.01). Response rates at 20 mg/kg were significantly 
different from O, 2.5, and 10 mg/kg (P < 0.05 in all cases 
by Tukey Gap test). 
To clarify the action of pentobarbital on choice 
behavior, a 
no-treatment 
experiment. 
significantly 
dose of 
trials in 
10 mg/kg was administered prior to 
10 subjects at the end of the 
If 
by 
performance accuracy was reduced 
this treatment it would provide further 
evidence for a state dependent explanation of the effect 
of pentobarbital on choice behavior in general, and not on 
PBQ discrimination specifically. 
The data, shown in Table 6, support this hypothesis. 
Three of the eight subjects able to respond at thi ,s dose 
(responding was completely suppressed in two subjects) 
chose the PBQ lever for responding. This is significantly 
di£ferent from baseline no-treatmebt discriminative 
performance (Xz df 1=3. 94, P < O .OS) • 
The effect of pentobarbital on PBQ discrimination 
dose not 
reasons. 
appear 
At the 
to be 
highest 
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an analgesic effect for several 
dose tested response rate 
performance was 
subjects tested 
greatly depressed, but over 50% of the 
still chose the PBQ correct lever for 
responding. If pentobarbital did possess significant 
analgesic activity it should have caused a greater 
decrease in PBQ lever selection at less suppressive doses. 
According to the dose response function, the EDSO value 
for pentobarbital in this respect would be 18 mg/kg. An 
effect of pentobarbital on recall of the previously 
acquired discrimination appears to be a more plausible 
explanation~ . Lever selection levels were approximately 
50% at all doses of pentobarbital u.tilized, a value which 
would be expected if recall of the task were interfered 
with and lever selection was made at random. 
This is an example of 
behavioral techniques where 
a disadvantage of operant 
learning and recall of a 
previously learned task are essential for valid assay of a 
drug•s effect. Treatments that interfere with memory 
function, especially recall, may become false positives or 
negatives if the data are not inspected carefully. In 
this case an analgesic false positive indication for 
pentobarbital can be tentatively ruled out since there was 
not a significant dose-response function which tended to 
produce complete bl .cckade of PBQ discrimination, even at 
high response-suppressing doses. 
A tricyclic antidepressant, amitriptyline, was tested 
for effects on PBQ treatment discrimination at four dose 
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levels; 5, 10, 20, and 40 mg/kg in 6 subjects each. From 
Figure 10 it can be seen that there was no significant 
overall dose-response effect on the discrimination 
(r=0.~5, F df1,3=2.19, P > 0.05). Although 50% of the 6 
subjects tested at 5 mg/kg responded on the non-PBQ 
treatment lever (X~df1=4.0, P < 0.05), this result was not 
consistent with further tests. At 20 mg/kg all but one of 
the 6 subjects tested (83%) responded on the PBQ 
appropriate lever, and at the next higher dose (40 mg/kg) 
two of the three subjects capable of responding chose the 
PBQ correct lever. This suggests that the 10 mg/kg result 
is due to random variation rather than an analgesic or 
other central nervous system effect of the amitriptyline 
treatment. The highest dose of amitriptyline reduced 
response rates significantly compared to all other doses 
(P < 0.05 in all cases by Tukey test, F df4,25=7.~43, P < 
0.01), which did not differ between themselves. 
PBQ at 10 mg/kg was administered to four experimental 
subjects with more than 25 total trials at 0.62 mg/kg PBQ, 
and produced substantial writhing behavior in all animals. 
Mean writhes for the four subjects in a 30 minute period 
were 10.Sz5. This value is not significantly different 
from that seen in PBQ naive animals chronically treated 
for six days, as seen in Table 5. 
At the end of the experiment an injection of 
physiological saline produced no writhing behavior in any 
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Figure 10 
Effect of Amitriptyline Pretreatment on PBQ Discrimination 
Discrimination test trials were carried out 5 minutes after 
administration of the training dose of 0.62 mg/kg PBQ, following 
pretreatment 60 minutes earlier with either 0, 5.0, 10, 20 or 
40 mg/kg amitriptyline given I.P. to 6 subjects at each dose. 
Amitriptyline doses are shown on the X axis. The percent of subjects 
tested at each dose who selected the PBQ appropriate lever for 
responding can be found on the Y axis. 
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of the subjects tested. A conditional · effect of the 
injection procedure as a component of the discrimination, 
resulting from repeated PBQ administration during training 
and testing, appears to be unlikely. 
In summary, the data of this section demonstrate that 
discrimination of the PBQ treatment can be blocked 
completely by the narcotic analgesic, morphine, and is 
significantly reduced by aspirin. Although pentobarbital 
and amitriptyline significantly reduced accuracy of PBQ 
choice behavior at certain doses, this appears to be due 
to other effects than analgesia as there were no 
significant dose response relations between drug treatment 
and lever selection for these compounds. Also, neither 
drug vas able to reduce PBQ choice to levels produced by 
either morphine or aspirin, even at doses which severely 
depressed response rates. The other centrally acting 
drugs tested, librium and haloperidol, had no significant 
effects on discrimination of PBQ treatment at doses which 
significantly depressed response rates. An examination of 
Figu .re 11 shows that morphine produces the most potent 
blockade of PBQ-treatment discrimination with the least 
response suppression. Pentobarbital and aspirin have 
similar slopes for PBQ-treatment discrimination blockade, 
but pentobarbital produces significant response rate 
decreases at a dose which has little or no blocking 
action. Any dose further along the the slope for blockade 
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Figure 11 
The Effect of Analgesic and Non-analgesic 
Drugs on PBQ Discrimination. 
A comparison of the effect of morphine (-), aspirin (····· · ·), 
pentobarbital (- - - -), and amitriptyline (-·- · - · -) on PBQ 
treatment discrimination. Vertical Markers (I) indicate the first 
dose of each drug which produced significant suppression of response 
rates from baseline. The X axis is dosage in mg/kg of body weight, 
while the percent of subjects tested at each dose who chose the P~Q 
lever for responding is shown on the Y axis. 
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of PBQ-treatment discrimination would be extremely 
debilitating and poEsibly lethal, the same is true with 
amitriptyline. 
It was also shown that sensitivity to the writhe 
inducing action of PBQ was not significantly attenuated by 
the chronic administration of the training dose during the 
course of the experiment. 
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General Discussion 
The operant procedure of PBQ treatment discrimination 
as evaluated by the three experiments included here, is a 
valid procedure for study of analgesic treatments, but 
needs some methodological modifications. In Experiment 
1, high doses of PBQ produced a reliable writhing response 
which was blocked by morphine. Since the response is 
centrally mediated, and may be interpreted as aversive in 
nature, the analgesic effect of morphine appears to be the 
primary drug action producing the writhing reduction. The 
local irritation and accompanying subjective aversive 
effect together comprise the experience of pain, and 
morphine blockade of EBQ writhing supports the operational 
definition of pain; drug-induced writhing blocked by a 
known analgesic. In this experiment a saline injection 
did not produce any writhing indicative of pain. To 
ascertain whether PEQ treatment could serve as · a 
discriminative stimulus, an injection of PBQ was presented 
prior to availability of food reinforcement from a 
particular location, and a saline injection preceded 
availability of reinforcement from a second location over 
many trials. The differential treatments attained 
significant control over lever pressing choice behavior 
for the group of 20 subjects in 70 trials. However, the 
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task was not maintained accurately. Only 7 of the 20 
subjects reached an acceptable performance criterion for 
demonstration of reliable task learning. This criterion 
was attained in a relatively large number of trials (49±8) 
when compared with acquisition of discrimination using a 
centrally acting drug such as morphine, which is typically 
learned in fewer than 35 trials (Miksic and Lal, 1977). 
In addition, the repeated PBQ treatment used for 
discrimination (1.~5 mg/kg) was quite toxic. Only four of 
the twenty subjects were able to complete more than 90 
total trials, although PBQ was not seen to significantly 
effect response rates as compared to saline treatment. It 
seemed possible that the PBQ-saline discrimination was in 
reality a discrimination between two different levels 
.and/or qualities of similar stimulation ("pain"), rather 
than a pain - no pain discrimination. Modifications in 
the discrimination training procedure were made when. 
Experiment 3 was initiated. To lower toxic effects of the 
repeated PBQ administration, the dose used for 
discrimination was reduced to 0.62 mg/kg; and the saline 
injection was eliminated on non-PBQ trials to increase the 
distinctiveness of the two discriminative conditions. 
These changes did not significantly affect rate of 
acquisition or reduce toxicity of the PBQ treatment. 
However, enough subjects were utilized so that a number of 
experimental manipulations could be applied on 
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post-criterion trials of subjects who demonstrated 
consistent performance. These tests indicated that 
discrimination of the PBQ treatment was dose-dependent and 
the threshold for discrimination, EDSO, was 0.26 mg/kg. 
Tests of the effects of a saline injection show that the 
stimuli produced by PEQ were not the only basis of the PBQ 
treatment discrimination. Forty percent of subjects 
treated with saline prior to a test trial chose the PBQ 
treatment lever for responding. The discriminative 
stimuli 
· solely 
produced by the PBQ treatment are therefore not 
due to the action of the PBQ itself, but represent 
a compound of which the PBQ action is the major component. 
This does not invalidate PBQ treatment discrimination as a 
measure of subjective "pain", but the stimuli cannot be 
described as resulting solely from internally produced 
visceral effects of PBQ. Although internal PBQ-induced 
irritation is the primary basis of the discrimination, the 
irritation produced by the injection procedure is a 
contributing factor. In order to make the pain inducing 
stimulus more specific in future experiments, 
administration could be via an indwelling I. P • . cannula. 
Further questions about the specificity of the PBQ 
treatment discriminative 
of 
stimulus 
centrally 
included 
acting 
whether 
drugs would non-specific 
generalize to 
effects 
the stimulus. To study this possibility 
haloperidol was administered two hours before a test 
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trial, when its peak action is in effect and the injection 
procedure is temporally separated from the test tr ·ial. 
Haloperidol depressed responding to a highly significant 
degree but had no effect on lever selection. This 
suggests that intense but non-specific central nervous 
system effects do not generalize to PBQ discriminative . 
stimuli. Injection of histamine, a substance which 
produces reports of intense pain when injected in man, 
resulted in PBQ treatment responding in all subjects 
tested without affecting response rate. This is further 
confirmation that the primary quality of the PBQ treatment 
that supports discriminative choice behavior is a . combined 
sensory-aversive experience, or pain. 
Pretreataent with the analgesics morphine and aspirin 
resulted in significant blockade of the PBQ treatment 
discrimination, thus demonstrating that the procedure is 
sensitive to analgesic effects of both narcotics and 
salicylates. Librium and haloperidol had no detectable 
effect on PBQ treatment discriminative choice behavior, 
while severely affecting response rate. Pentobarbital and 
amitriptyline had no significant dose-response effect on 
PBQ discrimination, although both drugs did show 
significant effects at specific doses. The test 
differentiates between the pentobarbital and amitriptyline 
effects, and those of analgesics, in that their effect on 
PBQ discrimination did not approach that produced by the 
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two analgesics nor did it result in a significant 
dose-response function for blockade even at doses which 
significantly depressed responding. The effect of 
pentobarbital on PBQ choice responding could 
hypothetically be explained as an effect on memory 
processes, specifically recall. Such an effect can be 
distinguished with tests of several doses. If task recall 
is interfered with, and analgesia does not play a role, 
choice behavior should be random and not differ 
significantly from 50% selection of either of the two 
possible responses. 
The advantages of this procedure as a model of 
subjectively experieoced "pain", or aversive stimulation, 
for evaluation of analgesic treatments include the 
following; it is based on an objective measure of 
subjective treatment effects and is thus more 
representative of human pain processes. Specific 
analgesic effects, detected via choice behavior, may be 
distinguished from ncn-specific excitatory and depressant 
effects which are reflected in response rates. The 
procedure can be utilized to investigate the relationship 
between different kinds of subjectively experienced 
aversive stimuli. 
Improvements in the task are also warranted, and 
should be investigated before it is accepted as a fully 
developed model for the study of pain perception. A main 
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-problem is toxicity which appears to interfere wi.th 
acquisition and maintenance of accurate performance and 
which necessitates continual training of new subjects to 
replace those lost during training and testing. PBQ 
appears to be an undesireable agent to act as the pain 
stimulus in this model. The procedure could be improved 
by using a drug or other treatment which produces 
significant 
chronically 
candidates 
interfere 
irritation without severe tissue damage when 
applied. Histamine and bradykinin are likely 
for 
with 
this 
memory 
role. Also, treatments which 
function are possible sources of 
false positive indications in 
several drug doses are tested 
inspected. 
analgesic tests unless 
and the data carefully 
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summary 
The evidence that PBQ treatment discrimination is 
based on a painful experience (as defined by specific 
blockade by analgesics, and generalization to the effects 
of other irritating chemicals) is of theoretical as well 
as practical importance. It is the first demonstration 
that laboratory animals will learn a two choice 
discriminative task based on both physical and aversive 
gualities of the stimulus. This was indicated by the 
morphine . blockade of PBQ discrimination. Morphine does 
not primarily act by disrupting sensory input but 
decreases the emotional component . of the experience in 
human clinical use. If the discrimination had been based 
only on the discriminability of peripheral sensory cues, 
morphine treatment would not have had a significant effect 
on choice performance once the task was acguired. It is 
~ 
interesting that aspirin, an anti-inflammatory agent, was 
not as effective in reducing discriminability of the PBQ 
treatment as was morphine, even at very high doses. 
It may be concluded that discrimination of the PBQ 
treatment qualifies as a model of subjectively experienced 
pain, which may be distinguished from non-specific 
stimuiation or depression. The model can, and should, be 
utilized with other aversive stimuli as the functional 
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aversive stimulus to be discriminated. 
Practical applications of this procedure include 
screening of potential analgesic treatments, and 
investigation of subjective pain processes. An example of 
the latter would be a task requiring the subject to 
discriminate between two types of painful stimuli, such as 
heat and electric shock. This would allow . study of 
differential effects of a single drug or other 
experimental treatment on two kinds or qualities of 
aversive stimuli. 
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'Appendix 1 
Experiment 3 Test Treatment Schedule 
Subject Order of Test Treatments 1 
1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ··· ·····26 27 
2 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 .•••••. 27 1 
3 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 .••••• 1 2 3 
4 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 •••••.. 
5 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 •••••• 
6 6 7 8 9 10 1112 13 14 15 16 17 18 19 20 21 22 ••• 
7 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 .•••• 
8 8 9 10 1112 13 14 15 16 17 18 19 20 21 .••.•• 
- 9 9 10 1112 13 14 15 16 17 18 19 20 21 •.•.••• 
10 10 1112 13 14 15 16 17 18 19 20 21 ••••••• 
11 1112 13 14 15 16 17 18 19 20 21 •••••• 
12 12 13 14 15 16 17 18 19 20 21 •••..• 
13 13 14 15 16 17 18 19 20 21 •••••• 
14 14 15 16 17 18 19 20 21 .•.••• 
15 15 16 17 18 19 20 21 ••.••• 
16 16 17 18 19 20 21 ••.•.. 
17 17 18 19 20 21 •••••• 
18 18 19 20 21 •••••. 
26 26 27 1 2 ••••• 
1 See Table 6 for treatments 1 through 27 respectively. 
This treatment schedule was subject to modification according to 
the following conditions. If 5 or more observations were sufficient 
to demonstrate blockade of PBQ discrimination as determined by a 
significant Chi-square analysis, or lack of blocking action at a response 
suppressing dose (as determined by analysis of variance with Tukey 
followup tests and Chi-square analysis), the remaining subjects scheduled 
for that treatment were used for the next scheduled treatment with the 
condition that a subject was not utilized for more than one dose of a 
drug if possible. 
A criterion performance level of at least 4 consecutive correct 
trials (2 PBQ and 2 no-treatment) was required for all subjects prior 
to any test. Approximately 50% of all pre-test trials were PBQ or saline. 
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